A variant with 50 mutations: omicron

Afew months ago, we were enjoying the reopening of civil society. But events intervened. First, the protection of two-dose vaccines started to subside. Second, unvaccinated patients, including children, were sickened by the furiously infectious omicron variant of SARS-CoV-2. More patients survive the omicron virus many experts say, but there are so many that the medical system can still be overwhelmed. Nursing and medical staff are exhausted, and patients with other diseases or conditions may not get the treatments they need.

On Jan. 6, in New York, the number of people with positive tests was 22.5%; in Connecticut, 29.1% and in Massachusetts, 21.8%. By the time you read this these numbers will be higher. Infections do not go on indefinitely — eventually there will be no uninfected or unvaccinated people.

Epidemiologists, or rather the clan of mathematical modelers among them, predict a crash in the number of infections by early February 2022. That may signal herd immunity and a change from pandemic status to endemic. The latter causes sporadic infection at low levels and tends not to overwhelm hospitals or harm the economy.

Omicron appeared in Botswana and South Africa in November 2021.  South African physicians have seen mild disease, and the infection is declining there. In the UK, some reports said severity is unaffected; others that the disease caused by omicron is milder than that caused by the Delta variant. The CDC’s Morbidity and Mortality Weekly Reports appears every Thursday and is online. It provides no conclusions yet on the severity of omicron on unvaccinated people, including children. Deaths do not seem to be increasing as rapidly as infections. In the early stage of a new infection or treatment, information comes in press reports, which can be written with more enthusiasm than data.  We will know more soon.

There are about 50 mutations in the omicron virus and a dozen in the delta variant. A virus-specific enzyme copies the RNA genome of SARS-CoV-2 but makes errors—30 have accumulated in the omicron spike protein and 20 in other omicron genes. Think of them as typos that the virus has not corrected. If the typos help the virus survive counterattack by the immune system, the typos (mutations) are retained. Each infected lung cell can make thousands of viruses, so the infection spreads fast. Since November, omicron, which makes about five times more virus than the original strain, has nearly replaced the delta variant.

You may wonder how any living thing survives viral onslaughts; the answer is that sometimes they don’t. When we do survive, it is because the human immune system is a wondrous collection of rapid defenses. Immunology is the science of engaging these defenses before a pathogen does. Think of it as an ambush. Immunity is as complicated as it is vital. I taught a course called The Cell Biology of Tissues and Organelles for beginning medical and dental students for 25 years.  Immunology flummoxed the students. It takes time to learn.

A group at Baylor College of Medicine and The Texas Children’s Hospital headed by Elena Bottazzi and Peter Hotez has fashioned a vaccine that does not employ an mRNA, but rather fragments of viral protein. The vaccine does not require refrigeration; a dose costs $1.50 and it is not patent protected. In India, the vaccine, called Corbevax, has been approved. It is an older method, but sometimes that is best.  A recent issue of Nature has a fine review on the status of COVID vaccines written for non-scientists.  Type “How COVID Vaccines Shaped 2021” into your browser to read it.

Treatments are being developed that stop infections, including immunoglobulins that can be inhaled. In the same vein, nanobodies, tiny antibodies made by Camelids (alpacas) neutralize omicron or other viruses. Think of an asthma inhaler spraying antibodies directly onto the virus in your lungs.

Drugs to inhibit viruses are a recent development — in the 1990s for HIV and now for other viruses. Pfizer has a drug called Paxlovid, which blocks the cleavage of viral proteins into functional units.  It is highly effective early after symptoms of COVID have appeared.  There are limited supplies, and the drug is tricky to make, but it will be in use shortly.

The Merck drug Molnupiravir blocks the enzyme that copies the virus genome. Molnupiravir is less effective at preventing symptoms that Paxlovid, but it interesting (to me) because it appear to inhibit other unpleasant RNA viruses. These include influenza; RSV, respiratory syncytial virus (a major cause of ER visits by children); norovirus (infections on cruise ships); Chikungunya virus (a mosquito-borne virus that causes severe joint pain); Venezuelan equine encephalitis virus); and hepatitis C. Perhaps we are at the beginning of a vast improvement in antiviral drug therapy.  Pray for it.

In the meantime, the best thing to do is get your vaccine and booster.  Let’s see if the epidemiologists are right and the peak comes soon. Watch positivity. Watch hospital admissions. Watch deaths from omicron. And hope for the best.

 

Rich Kessin is Emeritus Professor of Pathology and Cell Biology at the Columbia University Irving Medical Center.  Email Richard.Kessin@gmail.com.  See other columns on his website: Richardkessin.com.

The views expressed here are not necessarily those of The Lakeville Journal and The Journal does not support or oppose candidates for public office.

Latest News

Sharon voters reject controversial school budget, 114-99

The May 8 town meeting and budget vote were moved from Sharon Town Hall to Sharon Center School to accommodate what officials said was the largest turnout for a Sharon budget meeting in recent years.

Alec Linden

SHARON – More than 200 residents packed the Sharon Center School gymnasium Friday, May 8, where voters narrowly rejected the Sharon Board of Education's proposed 2026-2027 spending plan by a vote of 114-99, sending the budget back to the Board of Finance after weeks of heated debate over school funding.

The rejected proposal – the ninth version of the budget since deliberations began months ago – carried a bottom line of $4,165,513 for the elementary school, unchanged from last year. The flat budget came after the BOF ordered the BOE in early April to remove nearly $70,000 from its spending plan.

Keep ReadingShow less

Liane McGhee

Liane McGhee
Liane McGhee
Liane McGhee

Liane McGhee, a woman defined by her strength of will, generosity, and unwavering devotion to her family, passed away leaving a legacy of love and cherished memories.

Born Liane Victoria Conklin on May 27, 1957, in Sharon, CT, she grew up on Fish Street in Millerton, a place that remained close to her heart throughout her life. A proud graduate of the Webutuck High School Class of 1975, Liane soon began the most significant chapter of her life when she married Bill McGhee on August 7, 1976. Together, they built a life centered on family and shared values.

Keep ReadingShow less
‘Women Laughing’ celebrates New Yorker cartoonists

Ten New Yorker cartoonists gather around a table in a scene from “Women Laughing.”

Eric Korenman

There is something deceptively simple about a New Yorker cartoon. A few lines, a handful of words — usually fewer than a dozen — and suddenly an entire worldview has been distilled into a single panel.

There is also something delightfully subversive about watching a room full of women sit around a table drawing them. Not necessarily because it seems unusual now — thankfully — but because “Women Laughing,” screening May 9 at The Moviehouse in Millerton, reminds us that for much of The New Yorker’s history, such a gathering would have been nearly impossible to imagine.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

By any other name: becoming Lena Hall

By any other name: becoming Lena Hall

In “Your Friends and Neighbors,” Lena Hall’s character is also a musician.

Courtesy Apple TV
At a certain point you stop asking who people want you to be and start figuring out who you already are.
Lena Hall

There is a moment in conversation with actress and musician Lena Hall when the question of identity lands with unusual force.

“Well,” she said, pausing to consider it, “who am I really?”

Keep ReadingShow less
Remembering Todd Snider at The Colonial Theatre

“A Love Letter to Handsome John” screens at The Colonial Theatre on May 8.

Provided

Fans of the late singer-songwriter Todd Snider will have a rare opportunity to gather in celebration of his life and music when “A Love Letter to Handsome John,” a documentary by Otis Gibbs, screens for one night only at The Colonial Theatre in North Canaan on Friday, May 8.

Presented by Wilder House Berkshires and The Colonial Theatre, the 54-minute film began as a tribute to Snider’s friend and mentor, folk legend John Prine. Instead, following Snider’s death last November at age 59, it became something more intimate: a portrait of the alt-country pioneer during the final year of his life.

Keep ReadingShow less
Sharon Playhouse debuts new logoahead of 2026 season

New Sharon Playhouse logo designed by Christina D’Angelo.

Provided

The Sharon Playhouse has unveiled a new brand identity for its 2026 season, reimagining its logo around the silhouette of the historic barn that has long defined the theater.

Sharon Playhouse leadership — Carl Andress, Megan Flanagan and Michael Baldwin — revealed the new logo and website ahead of the 2026 season. The change reflects leadership’s desire to embrace both the Playhouse’s history and future, capturing its nostalgia while reinventing its image.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.